These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 26719541)
1. Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte-Endothelial Recognition to Foster Tumor Immune Escape. Corey DM; Rinkevich Y; Weissman IL Cancer Res; 2016 Mar; 76(6):1348-53. PubMed ID: 26719541 [TBL] [Abstract][Full Text] [Related]
2. Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow. Shimonaka M; Katagiri K; Nakayama T; Fujita N; Tsuruo T; Yoshie O; Kinashi T J Cell Biol; 2003 Apr; 161(2):417-27. PubMed ID: 12707305 [TBL] [Abstract][Full Text] [Related]
3. VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation. Huang H; Langenkamp E; Georganaki M; Loskog A; Fuchs PF; Dieterich LC; Kreuger J; Dimberg A FASEB J; 2015 Jan; 29(1):227-38. PubMed ID: 25361735 [TBL] [Abstract][Full Text] [Related]
4. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors. Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578 [TBL] [Abstract][Full Text] [Related]
5. The Peyer's patch high endothelial receptor for lymphocytes, the mucosal vascular addressin, is induced on a murine endothelial cell line by tumor necrosis factor-alpha and IL-1. Sikorski EE; Hallmann R; Berg EL; Butcher EC J Immunol; 1993 Nov; 151(10):5239-50. PubMed ID: 7693807 [TBL] [Abstract][Full Text] [Related]
6. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. Hänninen A; Taylor C; Streeter PR; Stark LS; Sarte JM; Shizuru JA; Simell O; Michie SA J Clin Invest; 1993 Nov; 92(5):2509-15. PubMed ID: 7693764 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factor-kappaB pathway. Min JK; Lee YM; Kim JH; Kim YM; Kim SW; Lee SY; Gho YS; Oh GT; Kwon YG Circ Res; 2005 Feb; 96(3):300-7. PubMed ID: 15637298 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973 [TBL] [Abstract][Full Text] [Related]
17. Calreticulin promotes tumor lymphocyte infiltration and enhances the antitumor effects of immunotherapy by up-regulating the endothelial expression of adhesion molecules. Wang HT; Lee HI; Guo JH; Chen SH; Liao ZK; Huang KW; Torng PL; Hwang LH Int J Cancer; 2012 Jun; 130(12):2892-902. PubMed ID: 21805477 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4. Matsumoto K; Nakamura T; Sakai K; Nakamura T Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008 [TBL] [Abstract][Full Text] [Related]
19. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723 [TBL] [Abstract][Full Text] [Related]
20. Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma. Nummer D; Suri-Payer E; Schmitz-Winnenthal H; Bonertz A; Galindo L; Antolovich D; Koch M; Büchler M; Weitz J; Schirrmacher V; Beckhove P J Natl Cancer Inst; 2007 Aug; 99(15):1188-99. PubMed ID: 17652277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]